Works matching IS 13899600 AND DT 2021 AND VI 20 AND IP 4
Results: 14
The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 363, doi. 10.1007/s10689-021-00266-w
- By:
- Publication type:
- Article
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 337, doi. 10.1007/s10689-021-00264-y
- By:
- Publication type:
- Article
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 295, doi. 10.1007/s10689-021-00263-z
- By:
- Publication type:
- Article
Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 355, doi. 10.1007/s10689-021-00258-w
- By:
- Publication type:
- Article
Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 279, doi. 10.1007/s10689-021-00254-0
- By:
- Publication type:
- Article
Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 317, doi. 10.1007/s10689-021-00247-z
- By:
- Publication type:
- Article
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Correction to: Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 273, doi. 10.1007/s10689-021-00234-4
- By:
- Publication type:
- Article
Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 263, doi. 10.1007/s10689-021-00237-1
- By:
- Publication type:
- Article
Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 257, doi. 10.1007/s10689-021-00233-5
- By:
- Publication type:
- Article
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 305, doi. 10.1007/s10689-021-00229-1
- By:
- Publication type:
- Article
Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 289, doi. 10.1007/s10689-021-00228-2
- By:
- Publication type:
- Article
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.
- Published in:
- Familial Cancer, 2021, v. 20, n. 4, p. 327, doi. 10.1007/s10689-020-00204-2
- By:
- Publication type:
- Article